Home | Verndari | transforming vaccines

Imagine being able to respond to a new influenza strain within the same flu season
with a painless room temp stable vaccine

Imagine the potential of increasing
vaccine production at lower cost.

The CDC recommends over 40 vaccinations for a child by age 6.
Imagine sparing the children over 30 needles

Vaccine Vision

Verndari was founded with the goal to eliminate needle phobia, and the need for the cold chain, with a cost-effective simple-to-use vaccination that can be mass produced. Verndari has developed a complete single-dose vaccination kit which includes VaxiPatch^TM. VaxiPatch is an “elegantly simple”...

Featured Article

Pharma company with UC Davis connection receives patent for painless vaccine technology Verndari Inc., a pharmaceutical company with laboratories at the UC Davis Medical Center, has received a patent for vaccines administered through adhesive skin patches. The technology, known as VaxiPatch, can be self-applied and is painless to the user, unlike typical vaccines that require a needle and syringe. The patent was issued to the company on July 17 and describes a method to manufacture the vaccine patches...

Trump signs executive order to improve flu vaccines

President Donald Trump yesterday issued an executive order directing the US Department of Health and Human Services (HHS) to overhaul seasonal flu vaccine production and urge more Americans to be vaccinated.